September 30, 2016 4:58 PM ET


Company Overview of Icagen, Inc. Prior to Merger with XRpro Sciences, Inc.

Executive Profile

Christine N. Sang M.D., M.P.H.

Member of Drug Discovery and Development Expert Panel, Icagen, Inc. Prior to Merger with XRpro Sciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships


Dr. Christine N. Sang, MD, MPH serves as Director of the Translational Pain Research Program of Brigham and Women's Hospital and Harvard Medical School. Dr. Sang has been Member of Drug Discovery and Development Expert Panel at Icagen, Inc., since June 1, 2007. Dr. Sang serves as special government employee with the Food and Drug Administration. She is an attending Physician at both the Brigham and Women's Hospital and Children's Hospital, Boston. She actively consults ...

Corporate Headquarters

4222 Emperor Boulevard
Durham, North Carolina 27703

United States

Phone: 919-941-5206
Fax: 919-941-0813

Board Members Memberships

There is no Board Members Memberships data available.


Master's Degree
Johns Hopkins School of Medicine
Johns Hopkins School of Medicine
Unknown/Other Education
Harvard School of Public Health
Harvard University
Master's Degree
Harvard University
MD 1989
Johns Hopkins University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Icagen, Inc. Prior to Merger with XRpro Sciences, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at